Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer Patients
- 1 January 2002
- journal article
- research article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 2 (4), 311-315
- https://doi.org/10.3816/cbc.2002.n.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patientsBritish Journal of Cancer, 1999
- Thrombopoietin Stimulates Endothelial Cell Motility and Neoangiogenesis by a Platelet-Activating Factor–Dependent MechanismCirculation Research, 1999
- Blood platelets and serum VEGF in cancer patientsBritish Journal of Cancer, 1998
- Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet ActivationThrombosis and Haemostasis, 1998
- Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patientsBritish Journal of Cancer, 1997
- Molecular Mechanisms Linking Thrombosis and Angiogenesis in CancerTrends in Cardiovascular Medicine, 1997
- Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateletsProceedings of the National Academy of Sciences of the United States of America, 1997
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Tumour stimulating effects of recombinant human interleukin-6The Lancet, 1994